28mm Ceramic-on-Ceramic Total Hip Replacement Study
Public ClinicalTrials.gov record NCT01657435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ceramax™ Ceramic-on-Ceramic Acetabular Cup Prothesis System
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is intended to gather medium (0-5 years) and long-term (6-10 years) information regarding the performance and safety of the commercially available Ceramax™ Ceramic on Ceramic Total Hip System. This is a two-phased study consisting of a clinical follow-up phase and a clinical outcomes phase. In Phase One (0-5 years), diagnostic, demographic and operative information will be gathered for each subject enrolled in this study. In addition, Harris Hip Evaluations, subjective evaluations and radiographs will be completed annually. In Phase Two (6 - 10 years), a subjective outcomes questionnaire and a SF-12 Health Survey will be mailed to subjects annually.
Study identification
- NCT ID
- NCT01657435
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Sep 23, 2019
- Completion
- Sep 23, 2019
- Last update posted
- Nov 18, 2019
2012 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Joint Surgeons of Sacremento | Sacramento | California | — | — |
| Colorado Joint Replacement | Denver | Colorado | 80210 | — |
| Not listed | Fort Collins | Colorado | — | — |
| Florida University | Gainesville | Florida | — | — |
| FOI Florida Orthopaedic Institute | Tampa | Florida | — | — |
| New England Baptist Hospital | Boston | Massachusetts | 02120 | — |
| Tufts - New England Medical Center | Boston | Massachusetts | — | — |
| Duke University | Durham | North Carolina | — | — |
| OrthoCarolina | Winston-Salem | North Carolina | — | — |
| Cardinal Orthopaedic Institute | Columbus | Ohio | — | — |
| UPenn | Philadelphia | Pennsylvania | 19104 | — |
| Anderson Orthopaedic Research Institute | Alexandria | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01657435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01657435 live on ClinicalTrials.gov.